BVI today said it appointed David Murray as chief financial officer, effective immediately.

Murray will report directly to president and CEO Shervin Korangy.

“David has joined BVI during a period of exceptional expansion for the business as we continue to build the fastest growing diversified ophthalmic business in the industry,” Korangy said in a news release. “He brings outstanding leadership to our team with an unmatched and unique experience set to help continue to drive BVI business into the future.”

Prior to joining BVI, Murray most recently served as chief financial officer of Alcon until its spin-off from Novartis in 2019. He has also held numerous leadership roles at General Motors, Swiss Bank Corp and British Petroleum.

“I am very pleased and excited to join Shervin and the BVI team,” Murray said. “having spent the past several years in the ophthalmology sector, I know it is an incredibly exciting space and that BVI is one of the most dynamic players out there. The BVI team’s vision for the future of the business is a compelling growth story that I look forward to helping shape while being instrumental in the execution of our strategies alongside the leadership team.”